- Home
- ARCT vs NCA Comparison
ARCT vs NCA Comparison
Compare ARCT & NCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- NCA
- Stock Information
- Founded
- ARCT 2013
- NCA 1987
- Country
- ARCT United States
- NCA United States
- Employees
- ARCT N/A
- NCA N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- NCA Investment Managers
- Sector
- ARCT Health Care
- NCA Finance
- Exchange
- ARCT Nasdaq
- NCA Nasdaq
- Market Cap
- ARCT 298.3M
- NCA 278.1M
- IPO Year
- ARCT N/A
- NCA N/A
- Fundamental
- Price
- ARCT $13.95
- NCA $8.48
- Analyst Decision
- ARCT Strong Buy
- NCA
- Analyst Count
- ARCT 8
- NCA 0
- Target Price
- ARCT $52.33
- NCA N/A
- AVG Volume (30 Days)
- ARCT 473.8K
- NCA 59.6K
- Earning Date
- ARCT 08-04-2025
- NCA 01-01-0001
- Dividend Yield
- ARCT N/A
- NCA 3.92%
- EPS Growth
- ARCT N/A
- NCA N/A
- EPS
- ARCT N/A
- NCA N/A
- Revenue
- ARCT $143,680,000.00
- NCA N/A
- Revenue This Year
- ARCT N/A
- NCA N/A
- Revenue Next Year
- ARCT $34.79
- NCA N/A
- P/E Ratio
- ARCT N/A
- NCA N/A
- Revenue Growth
- ARCT 15.38
- NCA N/A
- 52 Week Low
- ARCT $8.04
- NCA $7.77
- 52 Week High
- ARCT $27.54
- NCA $9.12
- Technical
- Relative Strength Index (RSI)
- ARCT 62.93
- NCA 52.29
- Support Level
- ARCT $12.03
- NCA $8.41
- Resistance Level
- ARCT $13.42
- NCA $8.48
- Average True Range (ATR)
- ARCT 0.81
- NCA 0.08
- MACD
- ARCT 0.09
- NCA 0.00
- Stochastic Oscillator
- ARCT 97.25
- NCA 45.00
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
About NCA Nuveen California Municipal Value Fund
Nuveen California Municipal Value Fund Inc is a diversified closed-end management investment company. Its primary objective is to provide current income exempt from regular federal and California income taxes. The fund's secondary objective is to enhance portfolio value relative to the California municipal bond market by investing in tax-exempt California municipal securities that the Fund's investment adviser and/or the Fund's sub-adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.